2021-22 Academic Calendar (PDF)
« All Events
Dr. Rahul Singhvi is a global leader in the life sciences industry and serves as the Chief Executive Officer of National Resilience, Inc.
Most recently, Singhvi was an Operating Partner at Flagship Pioneering, a Boston-based life sciences innovation firm, where he was responsible for founding and operating companies launched from Flagship’s innovation foundry, Flagship Labs. Before joining Flagship, Singhvi was the Chief Operating Officer of Takeda’s vaccine business unit, where he was responsible for worldwide vaccine CMC and manufacturing operations. Before Takeda, Singhvi was President and CEO of Novavax, Inc., where he transformed the company from a specialty pharmaceutical business to a vaccine development company. Singhvi’s professional career began at Merck & Co in 1994, where he held several positions in R&D and manufacturing.
Singhvi serves on the Executive Advisory Board of the Leonard Davis Institute of Health Economics at the University of Pennsylvania and on the Scientific Advisory Board of the anti-microbial resistance research group at the Singapore MIT Advance Research and Technology program. He is a mentor instructor in the Undergraduate Projects Opportunity Program at MIT and is a visiting lecturer at the University College London.
Dr. Singhvi graduated as the top ranked chemical engineer from the Indian Institute of Technology, Kanpur, India, and earned both his M.S. and Sc.D. chemical engineering degrees from MIT. He received an MBA from the Wharton School of the University of Pennsylvania, where he graduated as a Palmer Scholar.
Register here to receive Zoom log-in information.